Countries with the Highest Obesity Rates in the World (2025)

In 2022, the World Health Organization recorded that more than 1 billion people worldwide were living with obesity — approximately 880 million adults and 159 million children and adolescents aged 5 to 19. That is roughly 16% of the global adult population, up from under 5% in 1990. Obesity — defined clinically as a body mass index (BMI) of 30 or above — is now the leading modifiable risk factor for type 2 diabetes, cardiovascular disease, and at least 13 types of cancer.

The geography of this crisis is counterintuitive. The highest rates are not in the world's wealthiest countries, though the US, Gulf Arab states, and parts of Europe have serious problems. They are in small Pacific Island nations, where dietary transition from traditional foods to imported ultra-processed products has been rapid, complete, and devastating.

Source: WHO — Obesity and overweight fact sheet

Where this data comes from

The obesity statistics and country rankings in this article come from the WHO Global Health Observatory, which compiles prevalence data from national health surveys, medical records, and population studies. The World Obesity Federation also provides verified figures. All obesity rates reflect BMI ≥ 30 in adults, age-standardised to enable cross-country comparison. The data represents the most recent national measurement available, typically 2021–2023, drawn from Demographic and Health Surveys, national health ministries, and WHO estimates. The WHO acknowledges that measurement quality varies across countries: wealthy nations with systematic health surveillance have precise figures; countries without comprehensive health systems have estimates with larger margins of error. All figures should be understood as pointing-in-time snapshots, as obesity prevalence is rising globally and 2024 figures in most countries will be higher than 2023 figures reported here.

What BMI measures — and where it falls short

BMI is calculated by dividing a person's weight in kilograms by the square of their height in metres. A BMI of 18.5 to 24.9 is classified as healthy; 25 to 29.9 as overweight; 30 or above as obese. It is the standard metric for population-level obesity surveillance because it is simple, consistent, and requires no laboratory equipment.

Its limitations are well-documented. BMI does not distinguish muscle mass from fat mass — competitive athletes often register as "overweight" by BMI despite minimal body fat. It does not capture fat distribution, which matters clinically: visceral fat around the abdomen is more metabolically dangerous than subcutaneous fat, but both produce the same BMI. And the metric applies population-level thresholds developed from European populations to all human groups without adjustment.

That last point has measurable health consequences. Asian populations — particularly East and South Asian — tend to develop metabolic complications of excess fat at lower BMI thresholds than European populations. Several health authorities, including the WHO and the International Diabetes Federation, have proposed adjusted BMI cutoffs for Asian populations: overweight at BMI 23, obese at BMI 27.5. Japan uses its own national standards accordingly. This means Japan's "low" obesity rate of 4.3% is not directly comparable to the 42.0% US figure without methodological caveats.

Countries with the highest adult obesity rates

(Data: WHO Global Health Observatory, World Obesity Federation; BMI ≥ 30, age-standardised)

Rank	Country	Obesity rate (% adults, BMI ≥30)	Region
1	Nauru	61.0%	Pacific Islands
2	Cook Islands	55.9%	Pacific Islands
3	Palau	55.3%	Pacific Islands
4	Marshall Islands	52.9%	Pacific Islands
5	Tuvalu	51.6%	Pacific Islands
6	Niue	50.0%	Pacific Islands
7	Tonga	48.2%	Pacific Islands
8	Samoa	47.3%	Pacific Islands
9	Kiribati	46.0%	Pacific Islands
10	Micronesia	45.8%	Pacific Islands
11	Egypt	44.3%	North Africa
12	United States	42.0%	North America
13	Kuwait	37.9%	Middle East
14	Jordan	35.5%	Middle East
15	Saudi Arabia	35.4%	Middle East
20	Australia	29.0%	Oceania
25	Mexico	28.9%	Latin America
30	United Kingdom	27.8%	Europe
40	Germany	22.3%	Europe
50	France	17.0%	Europe
60	China	6.2%	East Asia
70	India	3.9%	South Asia
75	Japan	4.3%	East Asia
80	South Korea	6.0%	East Asia

Note: The US figure of 42.0% reflects 2022 WHO data, updated from the 36% figure in earlier datasets. Egypt's 44.3% similarly reflects significant increase between 1990 (19.4%) and 2022.

Source: WHO Global Health Observatory — Obesity prevalence data

How obesity is defined — and why the threshold matters

The BMI-30 threshold for "obese" is a statistical cut-point established through population health studies linking weight to disease outcomes. It is not a biological absolute — risks increase continuously with increasing BMI; the clinical classification into categories is a convenience for policy and communication, not a sharp biological boundary.

Clinically, obesity is now understood as a chronic, progressive, relapsing metabolic disease — not a simple equation of "eating too much." The WHO, the American Medical Association (which classified obesity as a disease in 2013), and major endocrinology bodies recognise that biological mechanisms — including hormonal dysregulation, genetic predisposition, gut microbiome composition, and the neurological effects of hyper-palatable foods — drive obesity independently of willpower or conscious choice. Body weight is also one of the factors covered in cancer prevention.

Genetic factors account for an estimated 40% to 70% of individual variation in obesity risk. This does not make obesity inevitable for people with high genetic risk; it means that environmental triggers produce different outcomes in different people. Identical caloric environments produce more obesity in genetically susceptible populations — which is precisely what happened in the Pacific Islands.

Why these countries lead in obesity rates

Pacific Island nations (Nauru 61%, Palau 55%, Marshall Islands 53%) dominate the highest-obesity rankings not because of genetic or cultural predisposition to obesity per se, but because of the speed and magnitude of dietary transition combined with genetic adaptation to resource scarcity. Pre-contact Pacific Islander populations were not obese on traditional diets of fish, taro, and coconut. The transformation to 61% obesity in two generations reflects imported processed food, trade policies, and limited access to traditional foods. The United States (42%) ranks high not because of American culture but because ultra-processed food comprises 58–60% of calories in the average diet, and car-dependent urban design has removed physical activity from daily life. The Middle East (Kuwait 37.9%, Saudi Arabia 35.4%) shows the same rapid transition pattern in oil-wealth-driven urbanisation: traditional diets replaced by imported processed food, car-dependent cities, and extreme heat discouraging outdoor activity. Japan (4.3%) and South Korea (6%) rank lowest not due to genetic difference but due to retained traditional dietary patterns (fish, vegetables, controlled portions), walkable urban design with high transit use, and in Japan's case, explicit government policy (the metabo law). The pattern demonstrates obesity is responsive to environmental factors: change the food environment and the activity environment, and obesity rates follow rapidly.

Why Pacific Island nations lead the world: a rapid dietary catastrophe

The Pacific Island obesity epidemic is one of the most extreme and historically recent diet-disease transitions ever documented. It requires understanding in three stages: what came before, what changed, and the genetic dimension that amplified the damage.

Before contact: the traditional Pacific diet. Traditional diets across Pacific Island cultures were based on fresh fish — the most abundant local protein source — alongside root vegetables (taro, breadfruit, sweet potato, cassava), coconuts, and tropical fruits. Physical activity was high: subsistence fishing, farming, and movement across islands. Pre-contact Pacific Islander populations were not obese; historical accounts from early European explorers describe lean, physically capable populations.

The dietary transition: imported food as status and necessity. Following World War II, US military presence introduced canned and processed foods throughout the Pacific. The transformation accelerated through the 1970s and 1980s as economies shifted from subsistence to cash-based, import-dependent structures. Traditional food production declined; imported processed foods became both cheaper and higher-status than local alternatives.

The specific composition of what was imported matters enormously. Turkey tails — the fatty, gristle-laden tail sections of turkeys, which are considered inedible in American consumer culture — found a large market in Pacific Island nations. Frozen turkey tails cost under $1 per pound, are calorie-dense (primarily fat), and lack meaningful nutritional value. Similar products — lamb flaps (fatty sheep offcuts), canned corned beef, canned spam — became dietary staples. These are literally the portions of animals that high-income countries' food systems reject, exported cheaply to Pacific markets. The health consequences were predictable.

Source: PMC — Food supply, nutrition and trade policy: reversal of turkey tail import ban

Samoa banned turkey tail imports in 2007 specifically because of their health impact — the most explicit acknowledgement by any government that an imported food product was causing a national health crisis. The ban was lifted in 2012 as a condition of Samoa's accession to the World Trade Organization, a stark example of trade liberalisation overriding public health policy.

The genetic amplification. Pacific Islander populations appear to have genetic variants affecting lipid metabolism and fat storage that were adaptive in pre-contact environments of food scarcity. A "thrifty genotype" — high efficiency at extracting and storing energy from food — is beneficial when food availability is uncertain. In environments of constant caloric surplus from high-fat processed foods, the same genetic variants become profoundly disadvantageous. This is not a simple explanation, and the thrifty genotype hypothesis remains debated in the literature, but the interaction between genetic background and dietary environment is well-established in Pacific populations.

The infrastructure constraint. Pacific Islands are small, remote, and economically dependent on imports. Fresh produce is expensive and poorly available. Fresh local fish — the traditional protein source — is frequently exported for export earnings rather than consumed locally. A family in Nauru may find imported processed food cheaper and more accessible than fresh local food, even in an island nation surrounded by ocean. This is the geography of food insecurity in the midst of apparent plenty.

The United States: the wealthiest country with a mass obesity problem

The US obesity rate of 42.0% (2022 WHO data, updated from earlier 36% estimates) is the highest among wealthy OECD nations — an outlier in a category usually occupied by Pacific Islands and Middle Eastern oil states. The US spends more on healthcare per capita than any other country and simultaneously has among the highest obesity rates in the developed world. Understanding this paradox requires looking at the food environment.

Approximately 58% to 60% of American caloric intake comes from ultra-processed foods — products manufactured from industrial ingredients (refined sugars, refined oils, starches, additives) rather than whole foods. Ultra-processed foods are engineered for palatability: combinations of fat, sugar, and salt calibrated to suppress natural satiety signals and encourage overconsumption. The food industry's internal research on "bliss points" — the precise ingredient ratios that maximise consumption — is now well-documented through litigation discovery and investigative journalism.

The geographic distribution of US obesity is not uniform. Food deserts — neighbourhoods with limited access to affordable fresh produce — concentrate in low-income and minority communities, where fast food chains are disproportionately dense. The correlation between poverty and obesity in the US runs opposite to global patterns: globally, wealth is associated with higher obesity; within the US, poverty is associated with higher obesity. This is because American food poverty is caloric abundance of poor-quality food, not caloric scarcity.

The built environment amplifies this. Most American cities and suburbs are designed around car travel, with minimal walkable infrastructure. The default physical activity level of an American who does not exercise intentionally is very low — walking is built out of daily life in most American communities. This contrasts with Tokyo or Copenhagen, where transit-dependent urban design builds physical activity into commuting and daily tasks.

Obesity-related healthcare costs in the US exceed $173 billion per year in direct medical expenditure, with broader economic costs — lost productivity, disability — estimated at over $400 billion annually. Smoking is another major preventable risk; see countries with the highest smoking rates.

The Middle East obesity surge: oil wealth and dietary disruption

Kuwait (37.9%), Jordan (35.5%), and Saudi Arabia (35.4%) have obesity rates rivalling or exceeding the United States, driven by a compressed version of the same dietary transition that affected Pacific Islands — but powered by oil-wealth-driven urbanisation rather than poverty-driven import dependency.

Gulf Arab states transitioned within a single generation from traditional diets based on dates, fish, camel milk, lamb, and rice to heavy reliance on Western fast food, ultra-processed products, and restaurant eating. The oil boom of the 1970s simultaneously raised incomes, urbanised populations, created desk-based employment economies, and flooded markets with imported processed food. Physical activity dropped as car-dependent urban design replaced walkable traditional town structures.

Hot climates — outdoor temperatures routinely exceeding 40°C (104°F) in summer — discourage outdoor physical activity in ways that make European-style active commuting culturally and physically difficult. Air-conditioned interiors become the default environment for most of the year.

The Gulf states now have some of the world's highest rates of type 2 diabetes as a direct consequence — with Saudi Arabia at approximately 18% adult diabetes prevalence, among the highest in the world.

Japan and South Korea: structural reasons for low obesity

Japan (4.3%) and South Korea (6%) are global outliers in low obesity, sitting well below most European nations despite being wealthy, urbanised, and fully exposed to global food industries. Several structural and cultural factors converge.

Traditional dietary patterns — built around fish, rice in controlled portions, vegetables, fermented foods (miso, natto, kimchi), and soups with minimal added fat — remain central to daily eating in both countries. Fast food is present and popular, but it has layered onto, rather than replaced, traditional dietary patterns. Japanese convenience store food, while processed, tends toward lower calorie density than American equivalents — rice balls, seaweed wraps, edamame — because the Japanese processed food market evolved from different culinary starting points.

Urban design is critical. Tokyo and Seoul are among the world's most walkable major cities. Public transit use is extremely high; car dependence is low by American standards. The average Tokyo resident walks significantly more per day as a function of simply commuting by train than the average American resident using a car. Incidental physical activity — embedded in daily life through urban structure — contributes meaningfully to caloric expenditure without requiring intentional exercise.

Japan enacted the metabo law in 2008 — a policy requiring waist measurements for all workers over 40 and mandating health interventions for those exceeding specific thresholds. Companies face financial penalties if their employees' collective health metrics are not improving. This is one of the world's most aggressive public policy responses to obesity prevention at population scale, and it has generated both results and significant controversy around medicalisation of body size.

GLP-1 drugs: a medical intervention at scale

Since approximately 2022, GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have produced weight loss outcomes in clinical trials that previous drug classes failed to achieve. Semaglutide produces an average of 15% body weight reduction over 68 weeks; tirzepatide has produced up to 22% in trials — approaching bariatric surgery outcomes through medication.

These drugs work by mimicking gut hormones that signal satiety to the brain, slowing gastric emptying, and reducing food-reward signalling. They do not simply suppress appetite; they appear to alter neurological food-seeking behaviour in ways that users describe as reducing the constant mental preoccupation with food that drives overconsumption.

The implications for population-level obesity rates, if access scales, are potentially significant. The questions remaining are: long-term safety with decade-scale use, whether metabolic benefits persist after stopping medication, cost and access equity (current monthly costs of $900 to $1,300 in the US), and whether reducing individual-level obesity through medication addresses the environmental causes that produce it in the first place.

Source: WHO — GLP-1 receptor agonist data

Q: Is BMI a reliable measure of obesity? A: BMI is the standard metric for population comparisons because it is simple and consistent. Its limitations are real: it does not distinguish muscle from fat, does not account for fat distribution, and misclassifies some individuals — athletes with high muscle mass and lean individuals with high visceral fat are both poorly served by BMI alone. Waist circumference and waist-to-hip ratio are better individual clinical tools. For population surveillance, BMI remains the most practical and widely used measure, with the caveat that Asian populations typically develop metabolic complications at lower BMI thresholds.

Q: Is obesity mainly about willpower and personal choice? A: The scientific consensus has shifted decisively away from this framing. Genetic factors account for 40% to 70% of obesity risk variation. Ultra-processed foods are engineered to override normal satiety signalling. Economic and built-environment factors constrain food and activity choices in ways that are not freely chosen. The WHO and American Medical Association both classify obesity as a chronic disease — not a character failure. This does not mean individual choices are irrelevant; it means those choices occur within biological, economic, and environmental contexts that powerfully constrain them.

Q: Are obesity rates still rising globally? A: Yes. WHO data shows the global adult obesity prevalence more than doubled between 1990 and 2022. The fastest current growth is in sub-Saharan Africa and Southeast Asia, where ultra-processed food markets are expanding into populations with previously low obesity rates. In wealthy Western countries, rates have largely plateaued at high levels — the US has been near 40% for over a decade — rather than continuing sharp increases. The Pacific Islands appear to have passed the acute phase of transition and stabilised at extremely high rates.

Q: What is the connection between obesity and poverty? A: Globally, obesity rates are higher in wealthier countries — the disease correlates with income at the national level. Within wealthy countries, obesity rates are higher among lower-income populations — the disease correlates inversely with income at the individual level. This apparent contradiction resolves when the food environment is considered: wealthy nations have food environments dominated by cheap, accessible ultra-processed calories; within those nations, wealthier individuals have greater access to higher-quality food, safer neighbourhoods for physical activity, and more time for health management.

Q: What are the most effective population-level obesity prevention strategies? A: Evidence-based interventions with demonstrated population impact include: sugar-sweetened beverage taxes (Mexico's 2014 soda tax reduced consumption by 12% in low-income households); front-of-package warning labels (Chile's black stop-sign labelling system); school food nutrition standards; urban design requirements for walkability and cycling infrastructure; restrictions on junk food advertising to children; and fiscal measures making fresh produce cheaper relative to processed food. No single intervention is sufficient; the evidence supports multi-component, environmental approaches over individual education campaigns.

Q: How do GLP-1 drugs compare to bariatric surgery for weight loss? A: Bariatric surgery (gastric bypass, sleeve gastrectomy) produces the largest and most durable weight loss — typically 25% to 35% of body weight with sustained metabolic benefits. GLP-1 agonists produce 15% to 22% weight loss — less than surgery but substantially more than previous drug classes. Surgery has higher immediate procedural risk; GLP-1 drugs have unknown long-term safety profiles beyond 3 to 5 years. Surgery is limited by access, cost, and physical eligibility; drugs are limited by cost, supply, and current access inequality. Both are being used in combination in some clinical settings.

The takeaway

Global obesity is not primarily about individual choices made in freely chosen environments. It is the predictable outcome of food systems engineered for caloric surplus, urban environments engineered for sedentary travel, trade policies that export nutritional harm alongside goods, and genetics shaped by very different historical environments. The Pacific Islands provide the clearest demonstration: populations that were lean for millennia on traditional diets became the world's most obese within two generations of dietary transition — driven by imported processed food, not personal failure. The United States demonstrates that the same dynamic operates in wealthy countries through different mechanisms: abundance of cheap ultra-processed calories, car-dependent cities, and food deserts that make poor nutritional choices the default for low-income populations. GLP-1 medications offer a medical tool that may bend obesity prevalence curves in ways no previous intervention has. The structural causes will persist regardless.

Related Reading

• Countries with the Lowest Infant Mortality
• Countries with the Best Healthcare Systems
• Countries with the Most Healthcare Spending
• Countries with the Most Doctors Per Capita
• Countries with the Best Quality of Life